Session Details

Session Details

01:30 PM - 03:15 PM - Ballroom 3

Johannes Van Der Loo - PhD - Children's Hospital of Philadelphia

Co-Chair

01:30 PM - 03:15 PM - Ballroom 3

Melanie Sorensen - Cytiva

Co-Chair

01:30 PM - 01:45 PM - Ballroom 3

Sandeep Mangrati - University College London

60: pAAVing the Way to High Titres: Plasmid Ratio Optimisation for AAV Production Utilising the Ambr 15 Stirred-Tank Bioreactor

01:45 PM - 02:00 PM - Ballroom 3

Hao Liu - PhD - Horae Gene Therapy Center, University of Massachusetts Chan Medical School

61: Producing High-Purity rAAV Vectors by Recombination-Dependent Minicircle Dual Transfection

02:00 PM - 02:15 PM - Ballroom 3

Hao Pan - Ph.D. - Predevelopment, Genomic Medicine Unit CMC, Sanofi

62: Elucidating the Function of Adenovirus Late Gene Products and Impact on AAV Production

02:15 PM - 02:30 PM - Ballroom 3

Alexander Burns - M.S., M.E. - Keck Graduate Institute

63: Process Development of HEK293-Based rAAV2 Manufacturing Platform

02:30 PM - 02:45 PM - Ballroom 3

Sandhya Pande - Associate Director - Shape Tx

64: Transforming AAV Vector Production with the TruStableTM AAV Producer Cell Line

02:45 PM - 03:00 PM - Ballroom 3

Matteo Placidi - PhD - Voyager Therapeutics

65: Developability Assessment of Novel AAV Capsids and Payloads at Early Preclinical Stage to Enable Development of Gene Therapies

03:00 PM - 03:15 PM - Ballroom 3

Angela Johnson - PhD, MSE, RAC - Cytiva

66: Comparative Analysis of Sterile Grade Filters in Adeno-Associated Virus (AAV) Manufacturing: Accelerating First-in-Human AAV Therapeutic Production with Quality by Design Principles